Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced that the European Commission has officially initiated the review and…
CGT Global, a leader in cell and gene therapy access, is proud to announce their support for the Conrad Breast Center at Renown South Meadows Medical Center in Reno, Nevada.…
-Global IT services provider FPT and Pharma Group jointly hosted the Healthcare Innovation Forum – HIF 2025. The event served as a multi-stakeholder dialogue platform with a spotlight on breakthrough…
Quantum Health (“Quantum”), the creator of healthcare navigation, has signed a definitive agreement to acquire Embold Health (“Embold”), a leading physician-led healthcare technology company. The transaction is expected to close within…
Altera Digital Health, a global healthcare IT leader, today announced it has entered into an agreement with Managed Care Advisory Group, Inc. (MCAG), one of the largest revenue recovery consulting firms, to…
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it has initiated the process with the U.S. Centers for Medicare and Medicaid Services (CMS) to seek reconsideration of…
TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies and…
-Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for…
Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA)De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict…
The NCSBN has released the NCLEX pass rates for Q1 of 2025 (January – March). Compared to Q1 of 2024, NCLEX pass rates have dropped in all categories. With large…
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of…
City of Hope Atlanta, part of one of the largest and most advanced cancer research and treatment organizations in the United States, is calling for urgent change in light of…